Global Stroke Management Market -
Regional Analysis
On the basis of region, Stroke
Management Market is segmented into North America, Latin America, Europe,
Asia Pacific, Middle East, and Africa. The substantial upsurge of geriatric
population in most of the economies is expected to drive growth of stroke
management market. According to the United Nations Department of Economic and
Social Affairs 2015 report, between 2015 and 2030 the number of people in the
world at the age of 60 years or above is projected to increase by 56% from 901
million to 1.4 billion. Moreover, over the next 15 years the number of older
persons is expected to grow fastest in Latin America and the Caribbean with a
projection of around 71%, followed by Asia with 66%, Africa by 64%, Northern
America by 41%, and Europe by 23% growth in old age population. Furthermore,
Asia Pacific is the fastest growing stroke management market region due to
upsurge in healthcare industry and increasing awareness for healthcare.
Stroke is a medical condition in
which blood clot blocks the blood vessels and interrupts the blood flow to the
brain, resulting in cell death. Under the guidelines of American Stroke
Association, there are of 3 types of strokes: ischemic stroke (an obstruction
within blood vessel that delivers blood to the brain), hemorrhagic stroke
(weakened blood vessel rapture due to high blood pressure), and transient
ischemic attack (identified by temporary clot). Stroke can be caused due to
medical conditions such as high blood pressure, diabetes, heart disease or life
style habits such as smoking, physically inactive lifestyle, alcohol abuse,
obesity, and various others. Moreover, uncontrollable factors such as
increasing age, male sex, heredity, and ethnicity contribute to stroke.
According to the World Health Organization (WHO), in 2015, stroke is the second
leading global cause of death after heart disease and it accounted for 11.8% of
total deaths worldwide.
Stroke management market is
driven by advancements in technology and therapeutic along with increasing
incidence of stroke and strict approval system is expected to hinder growth of
global stroke management market.
* The sample copy includes: Report Summary, Table of Contents,
Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1483
Global Stroke Management Market
Driver
The advancements in technology
and facilities to diagnose stroke and discovery of novel drugs will drive
growth of stroke management market. Technologies such as robotic-assisted
angiography or exoskeleton soft suit for rehabilitation are the upcoming future
of stroke management market. Moreover, an idea of Mobile Stroke Treatment Units
(MSTU) was introduced in Germany in 2003 and was used in Berlin for the first
time in 2008. The Prehospital Acute Neurological Treatment and Optimization of
Medical care in Stroke Study (PHANTOM-S) in Germany reported that their MSTU
significantly decreased stroke alert-to-treatment times from 76 minutes to 52
minutes, and significantly increased thrombolysis rates from 21% to 33% with no
increase in the risk of intracerebral hemorrhage. Therefore, advancements in
mobile stroke treatment units is expected to fuel growth of stroke management
market.
Conventional stroke treatment
aims at minimizing damage caused due to acute stroke by intravenous
thrombolytics and endovascular thrombectomy, however, there is no proven cure
for reversing the damage. It calls for a robust armamentarium of therapies for
stroke treatment such as cell therapy, which has immense potential to propel
the market in near future. Cell therapy can be used for re-vascularization
after stroke and for reduction of cerebral inflammation. Phase II clinical
trials of intravenous transplantation of autologous bone-marrow stem cells have
reported safety and tolerability in stroke patients. Other pending clinical
trials such as PISCES can also be considered as future candidates for clinical
practice. Sonothrombolysis is another approach, which uses low-frequency
ultrasound waves to cause thrombosis. The prototype for sonothrombolysis device
is been tested by North Carolina State University and has filed a patent on the
technology. Under equipped or untrained emergency medical service provider and
strict governmental regulations on the approval of new drugs or advanced
devices are some of the factors that are likely to hinder growth of stroke
management market.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/stroke-management-market-1483
The narrow range of drugs
available for the treatment of stroke offers wide options for research
organizations and key players to excel the stroke management market by
discovering novel drugs with less side-effects. Merger and acquisition is the
key strategy to expand the stroke management market. In May 2017, Codman Neuro,
a part of Johnson & Johnson acquired Neuravi Ltd., an Irish medical device
company that manufactures advance revascularization device and EmboTrap is a device
manufactured by this company. The EmboTrap platform was intended to address the
critical need for rapid restoration of blood flow in stroke patients and
combination of Neuravi’s expertise in clot research with Codman Neuro’s global
resources aims to accelerate development in the field of acute ischemic stroke
treatment. Furthermore, strong therapeutic pipeline of players will enhance
growth of stroke management market. In 2018, NuvOx Pharma’s dodecafluoropentane
emulsion (DDFPe) IV entered phase II clinical trials and DDFPe aims to deliver
oxygen to hypoxic tissue of brain. Also, in 2018, DiaMedica Therapeutics Inc.
announced DM199, a recombinant human tissue kallikrein, to enter phase II
clinical trial and it is expected to be a breakthrough in stroke treatment.
Global Stroke Management Market -
Competitors
Other major companies
contributing to the stroke management market include Abbott Laboratories, B.
Braun Melsungen AG, Boston Scientific Corporation, GE Healthcare,
GlaxoSmithKline Plc, Medtronic Plc, Merck & Co., Inc., and Cardinal Health.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1483
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment